Top Markets
#1 Helium Helium +52.72%
#2 Seeker Seeker +50.59%
#3 Pons Pons +35.63%
#4 UnifAI Network UnifAI Network +31.30%
#5 Zylo Ecosystem Zylo Ecosystem +25.79%
#6 VVS Finance VVS Finance +24.87%
#7 TENDIES TENDIES +19.47%
#8 Bounce Bounce +17.09%
#9 Tensor Tensor +15.98%
#10 Songbird Songbird +15.53%
Coin of the day
Helium Helium
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
BioSig Technologies, Inc. BioSig Technologies, Inc.

BioSig Technologies, Inc.

BSGM
Classifica tra le azioni #10875
BioSig Technologies, Inc., along with its subsidiaries, operates as a medical... BioSig Technologies, Inc., along with its subsidiaries, operates as a medical technology enterprise. Its core innovation is the PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology) system. This proprietary signal processing platform, merging specialized hardware and software, tackles well-known difficulties in electrophysiological signal acquisition, empowering electrophysiologists to instantaneously view and analyze vital cardiac signals. The system further enhances the collection of intracardiac signals and diagnostic data crucial for atrial fibrillation procedures. Moreover, it is specifically engineered to overcome persistent obstacles that traditionally slow down and complicate cardiac catheter ablation. BioSig also holds a research agreement with the University of Minnesota, targeting the development of new treatments for sympathetic nervous system disorders. Additionally, it has a strategic partnership with the Mayo Foundation for Medical Education and Research, focused on creating an advanced AI and machine learning software solution tailored for its PURE EP platforms. Established in 2009, BioSig Technologies, Inc. is headquartered in Westport, Connecticut.
Prezzo delle azioni
$5.52
Ultima sincronizzazione: 2025-10-09
Capitalizzazione di mercato
$775.10M
Variazione (1 giorno)
1.28%
Variazione (1 anno)
15.48%
Paese
US
Scambia BioSig Technologies, Inc. (BSGM)

Categoria

Healthcare
Ricavi di BioSig Technologies, Inc. (BSGM)
Ricavi nel Sep 2025 TTM: $13.00K
Secondo gli ultimi rapporti finanziari di BioSig Technologies, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $13.00K. Nel 2023, l'azienda ha registrato ricavi di $18.00K una diminuzione rispetto a i ricavi dell'anno 2022, che erano pari a $286.00K. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per BioSig Technologies, Inc. da 2011 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $13.00K -67.50%
2024 $40.00K 122.22%
2023 $18.00K -93.71%
2022 $286.00K -35.15%
2021 $441.00K 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 358,346,053.85%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 198,746,053.85%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 272,953,746.15%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 161,507,592.31%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE